When cancer costs too much: Why financial toxicity deserves a place in clinical conversations
Cancer care has long been associated with physical, emotional, and psychological hardship. But for many patients, a quieter burden (the financial strain of treatment) shapes their experience in equally profound ways. Increasingly referred to as financial toxicity, this form of distress is emerging as a key determinant of cancer outcomes. Yet it remains under-recognized in day-to-day clinical care.
The high price of staying alive
Financial toxicity describes the economic hardship caused by …